AI assistant
BZAM LTD. — Capital/Financing Update 2022
Dec 15, 2022
47394_rns_2022-12-15_d4822eba-f992-4520-b971-85ef44f54381.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
==> picture [113 x 112] intentionally omitted <==
The Green Organic Dutchman Holdings Ltd. C$6,000,000 Indicative Term Sheet
A final base shelf prospectus containing important information relating to the securities described in this document has been filed with the securities regulatory authorities in the provinces of Alberta, British Columbia and Ontario. A copy of the final short form base shelf prospectus, any amendment to the final base shelf prospectus and any applicable shelf prospectus supplement that has been filed, is required to be delivered with this document.
Copies of the final short form base shelf prospectus may be obtained from Clarus Securities Inc. at [email protected], and is also available electronically at www.sedar.com.
This document does not provide full disclosure of all material facts relating to the securities offered. Investors should read the final short form base shelf prospectus, any amendment and any applicable prospectus supplement for disclosure of those facts, especially risk factors relating to the securities offered, before making an investment decision.
The securities offered hereby have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”), or the securities laws of any state of the United States (as such term is defined in Regulation S under the U.S. Securities Act), and may not be offered or sold within the United States, or to, or for the account or benefit of a U.S. Person (as defined in Rule 902(k) of Regulation S under the U.S. Securities Act) or a person in the United States, except in transactions exempt from registration under the U.S. Securities Act and applicable U.S. state securities laws.
MARKETED OFFERING OF UNITS BY WAY OF PROSPECTUS SUPPLEMENT
| Issuer: | The Green Organic Dutchman Holdings Ltd. (the “Company”). |
|---|---|
| Offering: | A minimum of 12,500,000 units of the Company (the “Units”) up to a maximum of 15,000,000 |
| Units (the “Offering”). | |
| Offering Price: | C$0.40 per Unit (the “Issue Price”). |
| Offering Size: | A minimum of $5,000,000 up to a maximum of C$6,000,000 (C$6,900,000 if the Over- |
| Allotment Option (as defined below) is exercised in full). | |
| Issue: | Each Unit will consist of one common share in the capital of the Company (each, a “Common |
| Share”), and one Common Share purchase warrant (each warrant, a “Warrant”). Each | |
| Warrant will entitle the holder to purchase one Common Share at an exercise price of C$0.50 | |
| for 60 months following the completion of the Offering. | |
| Type of | The Offering will be offered by way of a prospectus supplement to the Company’s short form |
| Transaction: | base shelf prospectus dated November 27, 2020 pursuant to National Instrument 44-101 – |
| _Short Form Prospectus Distributions_and National Instrument 44-102 –_Shelf Distributions_as | |
| filed and to be filed, as applicable, in each of the provinces of Albert, British Columbia and | |
| Ontario. The Offering may also be made in the United States or to or for the account or benefit | |
| of “U.S. persons” as defined by Regulation S under the U.S. Securities Act on a private | |
| placement basis to a limited number of institutional “accredited investors” (as defined in Rule | |
| 501(a)(1), (2), (3), (7), (8), (9), (12) or (13) of Regulation D under the U.S. Securities Act and | |
| to “qualified institutional buyers” pursuant to Rule 144A or in such other manner as to not | |
| require registration under the U.S. Securities Act or any applicable securities laws of any state | |
| of the United States, and in other jurisdictions as mutually agreed by the Company and Clarus. |
| Over-Allotment | The Agent shall have an over-allotment option, exercisable in whole or in part, for a period of |
|---|---|
| Option: | 30 days from and including the closing date of the Offering to purchase up to an additional |
| 2,250,000 Units exercisable in whole or in part, for additional gross proceeds of C$900,000 | |
| on the same terms and conditions as the Offering (the “Over-Allotment Option”). | |
| Use of Proceeds: | The Company intends to use the net proceeds from the Offering for working capital and |
| general corporate purposes. | |
| Agent: | Clarus Securities Inc. |
| Fees: | A cash fee equal to 6.0% of the gross proceeds of the Offering shall be payable by the |
| Company to the Agent (including any gross proceeds raised on exercise of the Over-Allotment | |
| Option), excepting that portion of the Offering which is the subject of a “president’s list” (the | |
| “President’s List”), upon which a cash fee equal to 1.0% shall be payable. For further | |
| avoidance of the doubt, President’s List shall consist of insiders of the Company, | |
| Management, as well as Directors of the Company. | |
| Eligibility: | Eligible for investment in RRSPs, RRIFs, RESPs, DPSPs, and TFSAs. |
| Listing: | The Common Shares currently trade on the CSE under the symbol “TGOD”. |
| Closing Date: | On or about December 22, 2022, or such other earlier or later date as the Agent and Company |
| may agree upon. | |
| U.S. Notice: | The Units have not and will not be registered under the U.S. Securities Act or any U.S. state |
| securities laws and may not be offered or sold in the United States unless the Units have been | |
| registered under the U.S. Securities Act and any applicable state securities laws, or in | |
| compliance with the requirements of an exemption therefrom. |